Watermark
  Back to Search Results

BGB-3111-207

Completed

Study of BTK Inhibitor Zanubrutinib in Participants With Relapsed/Refractory Non-GCB Type Diffuse Large B Cell Lymphoma

BeOne Study ID Info icon SVG graphic used for tooltips or additional information.

BGB-3111-207

ClinicalTrials.gov ID Info icon SVG graphic used for tooltips or additional information.

NCT03145064

China Drug Trials ID Info icon SVG graphic used for tooltips or additional information.

CTR20170091

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

Study Documents

Study Protocol Statistical Analysis Plan

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

Study Documents

Study Protocol Statistical Analysis Plan